2018
DOI: 10.1016/j.biopha.2018.04.079
|View full text |Cite
|
Sign up to set email alerts
|

In vivo evaluation of antitumoral and antiangiogenic effect of imiquimod-loaded polymeric nanoparticles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(23 citation statements)
references
References 35 publications
0
23
0
Order By: Relevance
“…Since we have detected a different response to a vasoconstriction stimulus, we can speculate that the application of topical IMI may act also at a vascular level. Accordingly, a few recent studies have highlighted an antiangiogenic effect of topical IMI, thus suggesting a possible use in the treatment of hemangiomas [ 32 , 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…Since we have detected a different response to a vasoconstriction stimulus, we can speculate that the application of topical IMI may act also at a vascular level. Accordingly, a few recent studies have highlighted an antiangiogenic effect of topical IMI, thus suggesting a possible use in the treatment of hemangiomas [ 32 , 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…Each animal's dorsal skin was clipped 48 h before the experiment began in order to remove a 3 × 3 cm 2 area. A single dosage of the tumor initiator DMBA (1 mg in 200 µL acetone) was given subcutaneously to each mouse to generate a tumor [33]. Increased epidermal tumors which were larger and progressed more frequently to malignant carcinoma known as papillomas were observed after the injection of DMBA.…”
Section: In Vivo Anti-tumor Characterization Of Sle Gel Formulation 261 Study Designmentioning
confidence: 99%
“…The dorsal skin of each animal was clipped 48 hours before the experiment to remove a 3 × 3 cm 2 section. To create a tumour, each mouse was given a single dose of the tumour initiator DMBA (1 mg in 200 L acetone) [28]. Following the injection of DMBA, epidermal tumours became bigger and more commonly proceeded to malignant carcinoma (known as papilloma).…”
Section: In Vitro Characterization Of Optimum Rldl Formulation Gelmentioning
confidence: 99%
“…The quantification of the number and diameter of papilloma > 1 mm were investigated weekly to measure the antitumour activity of the RLDL formulation [28]. Additionally, histopathology estimation was obtained to confirm the antitumour activity and toxicity of the RLDL formulation.…”
Section: Antitumour Activity and Toxicity Determinationmentioning
confidence: 99%
See 1 more Smart Citation